Praxis Precision Medicines (PRAX) Tops Q3 EPS by 11c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q3 EPS of ($3.36), $0.11 better than the analyst estimate of ($3.47).

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Tradeweb adds spread trading for European credit portfolios
• Omnicom launches Acxiom Fan Graph sports marketing platform